Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)

Biotech stocks could see a bid tonight and tomorrow following Valeant Pharmaceuticals (NYSE: VRX) $73 per share bid for Cephalon, Inc. (Nasdaq: CEPH).

Here is a list of biotech companies mentioned as takeover targets in the past:
Biogen Idec Inc. (Nasdaq: BIIB), Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ), Dendreon Corp. (Nasdaq: DNDN), Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN), Human Genome Sciences Inc. (Nasdaq: HGSI), Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Onyx Pharmaceuticals Inc. (Nasdaq: ONXX).

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Samsung Plans As Much As $79 Billion In Shareholder Returns - Bloomberg
• Apple Cuts Jobs in Siri, Vision Pro 3D Video and Gaming Teams - Bloomberg